Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Richardson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Dermatology (Basel, Switzerland)|June 9, 2005
Novel application of layered expression scanning for proteomic profiling of plucked hair folliclesJune L Traicoff, Galina Baibakov, Greg Biesecker, et al.
Anticancer Research|January 31, 2012
The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapyFrank Richardson, G David Young, Regina Sennello, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumorsFrank Richardson, Chris Black, Katherine Richardson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancerFred R Hirsch, Fairooz Kabbinavar, Tim Eisen, et al.
The New England Journal of Medicine|July 15, 2005
Erlotinib in lung cancer - molecular and clinical predictors of outcomeMing-Sound Tsao, Akira Sakurada, Jean-Claude Cutz, et al.
Cancer Research|January 21, 2006
OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft modelsAndrew J Garton, Andrew P A Crew, Maryland Franklin, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Dermatology (Basel, Switzerland)|June 9, 2005
Novel application of layered expression scanning for proteomic profiling of plucked hair folliclesJune L Traicoff, Galina Baibakov, Greg Biesecker, et al.
Anticancer Research|January 31, 2012
The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapyFrank Richardson, G David Young, Regina Sennello, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Incorporation of OSI-7836 into DNA of Calu-6 and H460 xenograft tumorsFrank Richardson, Chris Black, Katherine Richardson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancerFred R Hirsch, Fairooz Kabbinavar, Tim Eisen, et al.
The New England Journal of Medicine|July 15, 2005
Erlotinib in lung cancer - molecular and clinical predictors of outcomeMing-Sound Tsao, Akira Sakurada, Jean-Claude Cutz, et al.
Cancer Research|January 21, 2006
OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft modelsAndrew J Garton, Andrew P A Crew, Maryland Franklin, et al.
Pageof 2